Several drugmakers are racing to develop vaccines that could protect against the new respiratory virus originating in China, as fears mount it could spread more widely. Moderna Inc., Inovio Pharmaceuticals Inc. and Novavax Inc. said Thursday they plan to develop vaccines against the newly identified viral strain, which emerged in the Chinese city of Wuhan. Researchers at the University of Queensland in Australia are also trying to develop a vaccine against the strain.

Source: Wall Street Journal January 23, 2020 21:02 UTC